Building a bayesian bridge from evidence to guidelines

Archives of Internal Medicine

Volumn 169, Issue 15, 2009, Pages 1436-1437

  Goodman, Steven N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; COST BENEFIT ANALYSIS; EVIDENCE BASED MEDICINE; NOTE; PRIORITY JOURNAL; PROBABILITY; STATISTICAL ANALYSIS;

ALGORITHMS; BAYES THEOREM; COST-BENEFIT ANALYSIS; CULTURE; EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PROBABILITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; UNCERTAINTY;

EID: 68849103900     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2009.254     Document Type: Note

References (10)

1. Diamond GA, Forrester JS. Clinical trials and statistical verdicts: probable grounds for appeal. Ann Intern Med. 1983;98(3):385-394.
2. Guidance for the use of Bayesian statistics in medical device clinical trials. www.fda.gov/MedicalDevices/DeviceRegulationandGuidance /GuidanceDocuments/ucm071072.htm. Accessed June 3, 2009.
3. Woodcock J, Temple R, Midthun K, Schultz D, Sundlof S. FDA senior management perspectives. Clin Trials. 2005;2:373-378.
4. Dunson DB. Bayesian nonparametric hierarchical modeling. Biom J. 2009;51 (2):273-284.
5. Scarpa B, Dunson DB. Bayesian hierarchical functional data analysis via contaminated informative priors [published online January 23, 2009] Biometrics. doi:10.1111/j.1541-0420.2008.01163.x.
6. Goodman SN. Towards evidence-based medical statistics, II: the Bayes factor. Ann Intern Med. 1999;130(12):1005-1013.
7. Kass RE, Raftery AE. Bayes factors. JASA. 1995;90:773-795.
8. Harris RP, Helfand M, Woolf SH, et al; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3)(suppl): 21-35.
9. Atkins D, Best D, Briss PA, et al; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490.
10. Miller J, Chan BK, Nelson HD. Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136(9): 680-690.